The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy Volunteers

Clinical trial NCT00985933 · COMPLETED

Trial details

NCT number: NCT00985933
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Healthy Memory Impairment

Start date: 2010-02-01
Primary completion: 2011-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.